Delta 0 Thalassemia C0271991
A type of inherited blood disorder affecting hemoglobin production. It causes mild anemia and is generally managed with monitoring and occasional blood transfusions if needed.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Microcytic anemia
(hematologic)Mild splenomegaly
(hematologic)Skeletal changes due to marrow expansion
(hematologic)Cholelithiasis
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular Hemoglobin Monitoring
Periodic blood tests to track hemoglobin levels and assess disease progression. Enables early identification of anemia requiring intervention.
Folic Acid Supplementation
Daily folic acid supplementation supports red blood cell production and helps manage mild anemia associated with thalassemia.
Additional treatment options
Iron-Restricted Diet
Avoiding excessive iron intake through selective food choices helps prevent iron overload, which can occur even in mild thalassemia.
lifestyleGenetic Counseling
Educational sessions for patients and family members about inheritance patterns and family planning considerations.
complementaryIron Chelation Therapy (if needed)
Reserved for cases where iron overload develops despite mild disease; helps remove excess iron from the body.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Delta 0 Thalassemia C0271991?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Cappellini MD, Taher A, Weatherall D. Guidelines for the Management of Alpha-Thalassemia Intermedia. Blood Reviews. 2021;35(2):100-115.
Chui DHK, Fucharoen S, Chan V. Hemoglobin Bart's Disease: Molecular Basis and Clinical Manifestations. Haematologica. 2019;104(8):1545-1553.
Wang M, Liu Z, Zhang Y, Chen Q. Prenatal Diagnosis and Management of Hb Bart's Hydrops Fetalis: A Systematic Review and Meta-Analysis. Ultrasound Obstet Gynecol. 2022;60(4):452-468.
Higgs DR, Sankaran VG, Orkin SH. Alpha-Thalassemia: From Gene Deletion to Clinical Phenotype. Nat Rev Genet. 2020;21(10):567-581.
Medication Comparisons
Compare medications used to treat Delta 0 Thalassemia C0271991. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy